Working… Menu
Trial record 1 of 10 for:    DNAse | Covid19
Previous Study | Return to List | Next Study

Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04541979
Recruitment Status : Recruiting
First Posted : September 9, 2020
Last Update Posted : February 25, 2021
Information provided by (Responsible Party):
Adam Linder, Region Skane

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2021
Estimated Study Completion Date : June 1, 2021